UncategorizedHCW Biologics initiates first‑in‑human trial of lead candidate HCW9302 – Longevity.Technology Empower Meds / November 19, 2025
UncategorizedAnnovis biomarker data link Alzheimer’s co-pathology to faster cognitive decline in Parkinson’s – Longevity.Technology Empower Meds / November 19, 2025
UncategorizedStartup emerges with $8m to combat musculoskeletal diseases Empower Meds / November 18, 2025
UncategorizedStartup aims to ‘change the script’ of age-related diseases Empower Meds / November 17, 2025
UncategorizedWVU RNI and Cognito Therapeutics launch brain health “collaboratory” – Longevity.Technology Empower Meds / November 17, 2025
UncategorizedCognision and Kynexis partner to study brain-function effects of KYN-5356 in schizophrenia – Longevity.Technology Empower Meds / November 17, 2025
UncategorizedBooster Therapeutics wins US$5 million grant from Michael J. Fox Foundation – Longevity.Technology Empower Meds / November 17, 2025
UncategorizedProtagenic Therapeutics completes enrollment and dosing in Phase 1 MAD study – Longevity.Technology Empower Meds / November 17, 2025
UncategorizedNiagen Bioscience launches Tru Niagen Beauty, the U.S.’s first NAD‑focused beauty supplement – Longevity.Technology Empower Meds / November 17, 2025
